An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice

Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review

(2015) A. Rabinovich et al.   THROMBOSIS RESEARCH

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

(2014) Maureen D. Mayes et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease

(2014) Theodoros Dimitroulas et al.   CURRENT PHARMACEUTICAL DESIGN

Kinetic Titration Series with Biolayer Interferometry

(2014) Daniel Frenzel et al.   PLoS One

IRF5polymorphism predicts prognosis in patients with systemic sclerosis

(2012) Roozbeh Sharif et al.   ANNALS OF THE RHEUMATIC DISEASES

Activation of Interferon Regulatory Factor 5 by Site Specific Phosphorylation

(2012) Hui-Chen Chang Foreman et al.   PLoS One

4F Decreases IRF5 Expression and Activation in Hearts of Tight Skin Mice

(2012) Hao Xu et al.   PLoS One

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

(2011) Thomas Krausgruber et al.   NATURE IMMUNOLOGY

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

(2011) Olga Gorlova et al.   PLoS Genetics

Phenotype-Haplotype Correlation of IRF5 in Systemic Sclerosis: Role of 2 Haplotypes in Disease Severity

(2010) P. DIEUDE et al.   JOURNAL OF RHEUMATOLOGY

Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5

(2008) Weijun Chen et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY